Literature DB >> 25381027

CFTR and lung homeostasis.

James F Collawn1, Sadis Matalon2.   

Abstract

CFTR is a cAMP-activated chloride and bicarbonate channel that is critical for lung homeostasis. Decreases in CFTR expression have dire consequences in cystic fibrosis (CF) and have been suggested to be a component of the lung pathology in chronic obstructive pulmonary disease. Decreases or loss of channel function often lead to mucus stasis, chronic bacterial infections, and the accompanying chronic inflammatory responses that promote progressive lung destruction, and, eventually in CF, lung failure. Here we discuss CFTR's functional role airway surface liquid hydration and pH, in regulation of other channels such as the epithelial sodium channel, and in regulating inflammatory responses in the lung.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  chronic obstructive pulmonary disease; cystic fibrosis; inflammatory responses; mucus obstruction; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25381027      PMCID: PMC4269691          DOI: 10.1152/ajplung.00326.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  79 in total

Review 1.  Regulation of ion transport by oxidants.

Authors:  Charles A Downs; My N Helms
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-06       Impact factor: 5.464

2.  The role of CFTR in transepithelial liquid transport in pig alveolar epithelia.

Authors:  James F Collawn; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-13       Impact factor: 5.464

3.  The cytokines interleukin-1β and tumor necrosis factor-α stimulate CFTR-mediated fluid secretion by swine airway submucosal glands.

Authors:  Nicholas Baniak; Xiaojie Luan; Amber Grunow; Terry E Machen; Juan P Ianowski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-08       Impact factor: 5.464

4.  Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κB in cystic fibrosis airway epithelial cells.

Authors:  Assem G Ziady; Andrew Sokolow; Samuel Shank; Deborah Corey; Ross Myers; Scott Plafker; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-30       Impact factor: 5.464

5.  CFTR is required for maximal transepithelial liquid transport in pig alveolar epithelia.

Authors:  Xiaopeng Li; Alejandro P Comellas; Philip H Karp; Sarah E Ernst; Thomas O Moninger; Nicholas D Gansemer; Peter J Taft; Alejandro A Pezzulo; Michael V Rector; Nathan Rossen; David A Stoltz; Paul B McCray; Michael J Welsh; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-05-25       Impact factor: 5.464

6.  The CFTR and ENaC debate: how important is ENaC in CF lung disease?

Authors:  James F Collawn; Ahmed Lazrak; Zsuzsa Bebok; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-04-06       Impact factor: 5.464

7.  Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration.

Authors:  Lucy A Clunes; Catrin M Davies; Raymond D Coakley; Andrei A Aleksandrov; Ashley G Henderson; Kirby L Zeman; Erin N Worthington; Martina Gentzsch; Silvia M Kreda; Deborah Cholon; William D Bennett; John R Riordan; Richard C Boucher; Robert Tarran
Journal:  FASEB J       Date:  2011-10-11       Impact factor: 5.191

8.  Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways.

Authors:  Alaina L Garland; William G Walton; Raymond D Coakley; Chong D Tan; Rodney C Gilmore; Carey A Hobbs; Ashutosh Tripathy; Lucy A Clunes; Sompop Bencharit; M Jackson Stutts; Laurie Betts; Matthew R Redinbo; Robert Tarran
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 9.  Cigarette smoke and CFTR: implications in the pathogenesis of COPD.

Authors:  Andras Rab; Steven M Rowe; S Vamsee Raju; Zsuzsa Bebok; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-09       Impact factor: 5.464

10.  A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.

Authors:  Peter A Sloane; Suresh Shastry; Andrew Wilhelm; Clifford Courville; Li Ping Tang; Kyle Backer; Elina Levin; S Vamsee Raju; Yao Li; Marina Mazur; Suzanne Byan-Parker; William Grizzle; Eric J Sorscher; Mark T Dransfield; Steven M Rowe
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more
  41 in total

Review 1.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

Review 2.  Airway hydration and COPD.

Authors:  Arunava Ghosh; R C Boucher; Robert Tarran
Journal:  Cell Mol Life Sci       Date:  2015-06-12       Impact factor: 9.261

3.  Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa.

Authors:  Roxanna Barnaby; Katja Koeppen; Amanda Nymon; Thomas H Hampton; Brent Berwin; Alix Ashare; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-16       Impact factor: 5.464

4.  Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia.

Authors:  Kaivon Assani; Chandra L Shrestha; Frank Robledo-Avila; Murugesan V Rajaram; Santiago Partida-Sanchez; Larry S Schlesinger; Benjamin T Kopp
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

Review 5.  Role of epithelial sodium channels in the regulation of lung fluid homeostasis.

Authors:  Sadis Matalon; Rafal Bartoszewski; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

6.  Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Mansi Kanhere; Jiabei He; Benoit Chassaing; Thomas R Ziegler; Jessica A Alvarez; Elizabeth A Ivie; Li Hao; John Hanfelt; Andrew T Gewirtz; Vin Tangpricha
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

Review 7.  Ion channels of the lung and their role in disease pathogenesis.

Authors:  Rafal Bartoszewski; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

8.  Therapeutic attenuation of the epithelial sodium channel with a SPLUNC1-derived peptide in airway diseases.

Authors:  James F Collawn; Rafal Bartoszewski; Ahmad Lazrak; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

Review 9.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

10.  Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations.

Authors:  Jennifer Guimbellot; George M Solomon; Arthur Baines; Sonya L Heltshe; Jill VanDalfsen; Elizabeth Joseloff; Scott D Sagel; Steven M Rowe
Journal:  J Cyst Fibros       Date:  2018-04-21       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.